⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
LLY News
Eli Lilly & Co.
Amylin Analogs and Combination Therapies Clinical Trial Landscape Expands as 15+ Leading Companies Accelerate Drug Development | DelveInsight
globenewswire.com
AZN
LLY
NVO
PFE
AMGN
BMY
JNJ
REGN
VKTX
ZETA
CRSP
IONS
AXSM
MRK
GSK
SNY
IMUX
BMEA
ALKS
ALT
AARD
NOV
CARM
CRIS
LPCN
GILD
REG
SPRO
ABSI
ALZN
ANVS
BV
ARCL
ACIU
Congestive Heart Failure Market to Register Immense Growth at a CAGR of 8% During the Forecast Period (2026-2036) | DelveInsight
prnewswire.com
CYTK
NVO
BCDA
AZN
BMY
LLY
MESO
ASMB
LXRX
VTRS
AMGN
IRWD
NVS
MRK
Scribe Therapeutics Announces Pricing of Upsized Initial Public Offering
globenewswire.com
SNY
LLY
Molecular Glues Clinical Trial Landscape: 80+ Emerging Competitors, Pipeline Dynamics, and Future Opportunities | DelveInsight
globenewswire.com
BMY
PFE
AMGN
NVS
MRK
LLY
GILD
AZN
TAK
JNJ
ABBV
CRSP
MOD
ARVN
ALK Inhibitors Market Set for Transformational Growth at a CAGR of 4% During the Forecast Period (2026-2036) Backed by Next-Generation Targeted Therapies| DelveInsight
prnewswire.com
PFE
MRK
LLY
AMGN
BMY
NVS
GILD
AZN
REGN
SNY
TEVA
IMUX
Lilly's triple agonist, retatrutide, successful in two additional Phase 3 obesity trials, delivering significant improvements in weight and A1C
prnewswire.com
LLY
AI in Drug Discovery Market worth $17.56 billion by 2031 - Exclusive Report by MarketsandMarkets™
prnewswire.com
NVDA
LLY
GOOG
MSFT
ILMN
Jeffrey Hayzlett, C-SUITE NETWORK™, Emovid™, and Didit Launch "Voices of 250" Initiative to Mobilize America's Business Leaders for the Nation's 250th Anniversary
prnewswire.com
NOC
LLY
NDAQ
Leading Healthcare Organizations Launch Initiative to Help Families Get Earlier Answers
prnewswire.com
LLY
Billions Flow Into Next-Generation Depression Treatments as Pharma Innovation Accelerates
prnewswire.com
HELP
ATAI
JNJ
CMPS
LLY